Vera Damuzzo
0000-0002-3685-6789
19 papers found
Refreshing results…
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data
Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave
CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
Safety of intravitreal injections: Non-inferiority of bevacizumab compared with ranibizumab
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy
Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study
Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs
A survey on patients medication reconciliation process in an oncological hospital
Case Study on an Ipilimumab Cost-Containment Strategy in an Italian Hospital
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
Myeloid-derived suppressor cell heterogeneity in human cancers.
Batf3-Dependent Dendritic Cells in the Renal Lymph Node Induce Tolerance against Circulating Antigens
Highlights on Molecular Mechanisms of MDSC-Mediated Immune Suppression: Paving the Way for New Working Hypotheses
Complexity and challenges in defining myeloid-derived suppressor cells
Missing publications? Search for publications with a matching author name.